« previous next »
Pages: [1]

Author Topic: Teriflunomide and liver injury research information (PubMed)  (Read 99 times)

0 Members and 0 Guests are viewing this topic.

Offline agate

  • Administrator
  • *****
  • Posts: 9480
  • MS diagnosed 1980
  • Location: Pacific Northwest
Teriflunomide and liver injury research information (PubMed)
« on: October 28, 2019, 04:12:17 pm »

Teriflunomide has a "likelihood score" of D ("possible cause of clinically apparent liver injury but experience with its use is limited") in the Overview section about it in LiverTox: Clinical and Research Information on Drug-Induced Liver Injury issued by the National Institute of Diabetes and Digestive and Kidney Diseases, recently indexed in Pub Med. This section of the report was last updated in January 2017..

https://www.ncbi.nlm.nih.gov/books/NBK548525/#Teriflunomide.OVERVIEW
« Last Edit: October 29, 2019, 07:25:27 pm by agate »
Report to moderator   Logged
MS Speaks--online for 16 years

SPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010. Glatopa (glatiramer acetate 40mg 3 times/week) since 12/16/20.
Pages: [1]
« previous next »
 

Related Topics

  Subject / Started by Replies Last post
0 Replies
123 Views 		Last post October 24, 2019, 04:29:04 pm
by agate
0 Replies
59 Views 		Last post October 25, 2019, 07:56:09 pm
by agate
0 Replies
130 Views 		Last post October 26, 2019, 03:31:32 pm
by agate
0 Replies
78 Views 		Last post October 26, 2019, 03:36:52 pm
by agate
0 Replies
105 Views 		Last post October 26, 2019, 03:38:12 pm
by agate